Related Experiment Video
Updated: Dec 21, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.1K
Drug repurposing against COVID-19: focus on anticancer agents
Gennaro Ciliberto1, Rita Mancini2, Marco G Paggi3
1Scientific Director, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Summary
Drug repurposing offers a rapid therapeutic strategy for COVID-19. This review analyzes existing cancer drugs as potential treatments for SARS-CoV-2 infection, accelerating emergency response.
Area of Science:
- Virology and Pharmacology
- Oncology and Infectious Diseases
Background:
- The COVID-19 pandemic necessitates rapid therapeutic development, a challenge given the lengthy drug discovery process.
- Traditional drug development timelines are insufficient for global health emergencies like the COVID-19 outbreak.
Purpose of the Study:
- To comprehensively review and analyze cancer drugs with potential for repurposing against SARS-CoV-2.
- To identify candidate cancer therapeutics that can be rapidly evaluated for COVID-19 treatment.
Main Methods:
- Exploration of drug repurposing as a viable alternative strategy for COVID-19 therapy.
- Analysis of commercially available drugs with established human dosage and toxicity profiles.
- Investigation of shared cellular mechanisms between virus-infected cells and cancer cells.
Main Results:
- Several drugs utilized in cancer therapy exhibit characteristics that may be effective against viral replication.
- Cancer drugs targeting enhanced nucleic acid, protein, lipid synthesis, and energy metabolism in cancer cells may also inhibit viral replication.
Conclusions:
- A comprehensive review of potential cancer drugs for repurposing in COVID-19 treatment is presented.
- This analysis aims to facilitate the fast-track evaluation of candidate drugs for SARS-CoV-2 infection.
More Related Videos
09:13Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
Published on: January 5, 2024
1.7K
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
4.2K
Related Concept Videos
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
01:26Targets for Drug Action: Overview
9.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.8K
01:26Drug Discovery: Overview
10.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.7K
01:28Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K